(-0.09%) 4 550.58 points
(0.04%) 35 430 points
(-0.16%) 14 258 points
(0.95%) $2 066.50
Live Chart Being Loaded With Signals
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea...
|EPS||$0 ( 2023-11-13 )|
|Last Dividend||$0 ( N/A )|
|Next Dividend||$0 ( N/A )|
|2023-08-14||Jayasuriya Anula||Buy||68 568||Common Stock|
|2023-07-01||Jayasuriya Anula||Buy||1 718||Common Stock|
|2023-07-01||Jayasuriya Anula||Sell||1 718||Restricted stock units|
|2023-08-14||Siegel Jonathan B.||Buy||68 568||Common Stock|
|2023-08-14||Micek John||Buy||68 568||Common Stock|
|Last 99 transactions|
|Buy: 5 684 092 | Sell: 480 279|
Jaguar Health Inc Correlation
|10 Most Positive Correlations|
|10 Most Negative Correlations|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Jaguar Health Inc Correlation - Currency/Commodity
Jaguar Health Inc Financials
|Gross Profit:||$9.94M (83.11 %)|
|Gross Profit:||$2.30M (81.73 %)|
|Gross Profit:||$2.19M (81.65 %)|
|Gross Profit:||$1.63M (82.51 %)|
Jaguar Health Inc
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer for multiple possible follow-on indications, including cancer therapy-related diarrhea; orphan-drug indications for symptomatic relief of diarrhea in infants and children with congenital diarrheal disorders and for adult and pediatric patients for short bowel syndrome with intestinal failure with; supportive care for diarrhea relief in inflammatory bowel diseases; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, it develops lechlemer, a second-generation anti-secretory agent for cholera; and Canalevia, an oral plant-based drug candidate to treat chemotherapy-induced diarrhea in dogs and exercise-induced diarrhea in dogs. Jaguar Health, Inc. was founded in 2013 and is headquartered in San Francisco, California.
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.